Search

everythinglearnresearchcommunity

for

Search:↓

Trichohyalin helps in hair and skin cell structure and function by binding calcium and linking proteins.

Desmoglein 3 organization in cell connections changes without calcium, affecting cell adhesion.

A new method creates valuable compounds for drug discovery by breaking traditional chemical rules.

A keratin hHb6 mutation causes a hair disorder with varying severity, influenced by other factors.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Phospholipids help plant proteins move by regulating receptor interactions.

Trichohyalin is found in non-hair tissues and works with filaggrin in certain skin areas and conditions.

A specific type II hair keratin was identified and found in hair cortex and tongue cells.

The salts have diverse molecular packing with significant hydrogen interactions.

Different Hairless isoforms affect Vitamin D receptor activity in hair regulation, with one repressing and the other stimulating it.

Keratins are crucial proteins for hair and nails, with a structure that helps teach protein principles.

The alpha-helix was confirmed as a key structure in proteins.

Vitamin D receptor and hairless protein are essential for hair growth.

EGF controls hair growth by regulating hair follicles' growth phases.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

HGF activator helps convert HGF to its active form, promoting hair growth.

RXRα is crucial for proper immune response and links diet to immune function.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Keratin structure changes during keratinization, but the exact model remains uncertain.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.